Scinovex
Subscribe
reviewTop 10% cited

Lopinavir/Ritonavir

Drugs · 2003 · Vol. 63(8) · pp. 769–802
R Cvetković✉Karen L. Goa
View via DOI Publisher page
HIV/AIDS drug development and treatmentHIV-related health complications and treatmentsHIV Research and TreatmentMedicineLopinavirRitonavirLopinavir/ritonavirPharmacotherapyPharmacologyIntensive care medicineVirologyInternal medicineHuman immunodeficiency virus (HIV)

MeSH terms

Clinical Trials as TopicDrug Administration ScheduleDrug InteractionsHumansHIV-1HIV InfectionsHIV Protease InhibitorsRitonavirDrug Resistance, Viral
Citations
436
FWCI
10.65
field-weighted impact
References
72
Percentile
99%
vs. same field & year
Citations per year
Cited by
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Thorax · 2004 · 1,698 citations
References
Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
AIDS · 1998 · 537 citations
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
AIDS · 1998 · 2,400 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.